Affordable Access

Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.

Authors
  • Jeremić, Branislav
  • Milicić, Biljana
  • Acimović, Ljubisa
  • Milisavljević, Slobodan
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
Oct 01, 2005
Volume
23
Issue
28
Pages
6873–6880
Identifiers
PMID: 16192579
Source
Medline
License
Unknown

Abstract

Hfx RT and concurrent low-dose daily carboplatin/paclitaxel was feasible with low toxicity and effective in patients with stage I/II non-small-cell lung cancer. It should continue to be investigated for this disease.

Report this publication

Statistics

Seen <100 times